{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:23:22Z","timestamp":1747175002724,"version":"3.40.5"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Kidney Disease and Health"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1053\/j.akdh.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T20:22:13Z","timestamp":1732134133000},"page":"566-573","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transplant Nephrology"],"prefix":"10.1053","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-632X","authenticated-orcid":false,"given":"Donal J.","family":"Sexton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Bagnasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5863-3562","authenticated-orcid":false,"given":"Sam","family":"Kant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.akdh.2024.08.004_bib1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1177\/1522162802238454","article-title":"BK virus: Discovery, epidemiology, and biology","volume":"5","author":"Randhawa","year":"2002","journal-title":"Graft"},{"issue":"8","key":"10.1053\/j.akdh.2024.08.004_bib2","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/v14081616","article-title":"BK virus nephropathy in kidney transplantation: a state-of-the-art review","volume":"14","author":"Kant","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.transproceed.2018.12.016","article-title":"Renal function impairment in kidney transplantation: Importance of early BK virus detection","volume":"51","author":"Manzano S\u00e1nchez","year":"2019","journal-title":"Transplant Proc"},{"issue":"7","key":"10.1053\/j.akdh.2024.08.004_bib4","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1053\/j.akdh.2024.08.004_bib5","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1111\/j.1600-6143.2005.01000.x","article-title":"Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia","volume":"5","author":"Bohl","year":"2005","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1053\/j.akdh.2024.08.004_bib6","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2215\/CJN.00770112","article-title":"Incidence and outcomes of BK virus allograft nephropathy among ABO- and HLA-incompatible kidney transplant recipients","volume":"7","author":"Sharif","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.08.004_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13528","article-title":"BK polyomavirus in solid organ transplantation\u2014guidelines from the american society of transplantation infectious diseases community of practice","volume":"33","author":"Hirsch","year":"2019","journal-title":"Clin Transplant"},{"issue":"Suppl 3","key":"10.1053\/j.akdh.2024.08.004_bib8","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-3062.2006.00154.x","article-title":"Polyomavirus-associated nephropathy: update in diagnosis","volume":"8","author":"Drachenberg","year":"2006","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1053\/j.akdh.2024.08.004_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/TP.0b013e3181d0e15e","article-title":"Treatment of polyomavirus infection in kidney transplant recipients: a systematic review","volume":"89","author":"Johnston","year":"2010","journal-title":"Transplantation"},{"issue":"1","key":"10.1053\/j.akdh.2024.08.004_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/ajt.16233","article-title":"Intravenous immunoglobulin as a preventive strategy against BK virus viremia and BKV-associated nephropathy in kidney transplant recipients\u2014results from a proof-of-concept study","volume":"21","author":"Benotmane","year":"2021","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib12","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.transproceed.2015.01.012","article-title":"Efficacy of intravenous immunoglobulin in the treatment of persistent BK viremia and BK virus nephropathy in renal transplant recipients","volume":"47","author":"Vu","year":"2015","journal-title":"Transplant Proc"},{"issue":"4","key":"10.1053\/j.akdh.2024.08.004_bib13","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1097\/TXD.0000000000000641","article-title":"Clearance of BK virus nephropathy by combination antiviral therapy with intravenous immunoglobulin","volume":"3","author":"Kable","year":"2017","journal-title":"Transplantation Direct"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1111\/ajt.15723","article-title":"Outcomes of kidney retransplantation after graft loss as a result of BK virus nephropathy in the era of newer immunosuppressant agents","volume":"20","author":"Leeaphorn","year":"2020","journal-title":"Am J Transplant"},{"issue":"6380","key":"10.1053\/j.akdh.2024.08.004_bib15","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/357692a0","article-title":"FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin","volume":"357","author":"O'Keefe","year":"1992","journal-title":"Nature (London)"},{"issue":"7","key":"10.1053\/j.akdh.2024.08.004_bib16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncpneph0225","article-title":"Primer: Histopathology of calcineurin-inhibitor toxicity in renal allografts","volume":"2","author":"Ivanyi","year":"2006","journal-title":"Nat Clin Pract Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.08.004_bib17","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.transproceed.2004.08.006","article-title":"Primary immunosuppression with tacrolimus in kidney transplantation: Three-year follow-up in a single center","volume":"36","author":"Kim","year":"2004","journal-title":"Transplant Proc"},{"issue":"10","key":"10.1053\/j.akdh.2024.08.004_bib18","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/nm.2497","article-title":"The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension","volume":"17","author":"Hoorn","year":"2011","journal-title":"Nature medicine"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1399-0012.2003.00154.x","article-title":"Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression","volume":"18","author":"Heering","year":"2004","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1053\/j.akdh.2024.08.004_bib20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1053\/j.ajkd.2018.12.023","article-title":"Metabolic acidosis 1 year following kidney transplantation and subsequent cardiovascular events and mortality: an observational cohort study","volume":"73","author":"Djamali","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1053\/j.akdh.2024.08.004_bib21","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1681\/ASN.2016070793","article-title":"Metabolic acidosis and long-term clinical outcomes in kidney transplant recipients","volume":"28","author":"Park","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1053\/j.akdh.2024.08.004_bib22","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1111\/j.1600-6143.2009.02752.x","article-title":"Posttransplantation hypomagnesemia and its relation with immunosuppression as predictors of New-Onset diabetes after transplantation","volume":"9","author":"Van Laecke","year":"2009","journal-title":"Am J Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2024.08.004_bib23","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00007890-199704150-00013","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 kidney transplant study group","volume":"63","author":"Pirsch","year":"1997","journal-title":"Transplantation"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib24","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: Impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl Int"},{"issue":"6","key":"10.1053\/j.akdh.2024.08.004_bib25","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1159\/000495081","article-title":"Trends in the causes of death among kidney transplant recipients in the United States (1996\u20132014)","volume":"48","author":"Awan","year":"2018","journal-title":"Am J Nephrol"},{"issue":"7","key":"10.1053\/j.akdh.2024.08.004_bib26","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1111\/j.1600-6143.2005.00969.x","article-title":"Reproduction and transplantation: report on the AST consensus conference on reproductive issues and transplantation","volume":"5","author":"McKay","year":"2005","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1053\/j.akdh.2024.08.004_bib27","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"issue":"11","key":"10.1053\/j.akdh.2024.08.004_bib28","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1111\/j.1600-6143.2011.03656.x","article-title":"Pregnancy outcomes in kidney transplant recipients: a systematic review and Meta-Analysis","volume":"11","author":"Deshpande","year":"2011","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.08.004_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173420","article-title":"Preeclampsia in kidney transplanted women; outcomes and a simple prognostic risk score system","volume":"12","author":"Majak","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.akdh.2024.08.004_bib30","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000002708","article-title":"ACOG committee opinion no. 743: low-dose aspirin use during pregnancy","volume":"132","author":"Manuck","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"10","key":"10.1053\/j.akdh.2024.08.004_bib31","first-page":"CD002252","article-title":"Antihypertensive drug therapy for mild to moderate hypertension during pregnancy","volume":"2018","author":"Abalos","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/HYPERTENSIONAHA.112.196352","article-title":"Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors or angiotensin receptor antagonists: a systematic review","volume":"60","author":"Bullo","year":"2012","journal-title":"Hypertension (Dallas, Tex. 1979)"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib33","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/S0041-1345(98)00408-4","article-title":"Pregnancy outcomes in female renal transplant recipients","volume":"30","author":"Armenti","year":"1998","journal-title":"Transplant Proc"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2215\/CJN.06170612","article-title":"Pregnancy in renal transplant recipients: a UK national cohort study","volume":"8","author":"Bramham","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.akdh.2024.08.004_bib35","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The banff 2022 kidney meeting report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib36","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1097\/TP.0000000000001115","article-title":"The risk of transplant failure with HLA mismatch in first adult kidney allografts from deceased donors","volume":"100","author":"Williams","year":"2016","journal-title":"Transplantation"},{"issue":"6","key":"10.1053\/j.akdh.2024.08.004_bib37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5500\/wjt.v7.i6.339","article-title":"Human leukocyte antigen typing and crossmatch: a comprehensive review","volume":"7","author":"Althaf","year":"2017","journal-title":"World J Transplant"},{"issue":"7","key":"10.1053\/j.akdh.2024.08.004_bib38","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.3390\/biomedicines10071506","article-title":"Non-HLA antibodies in kidney transplantation: Immunity and genetic insights","volume":"10","author":"Sorohan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1053\/j.akdh.2024.08.004_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686271","article-title":"Current approaches to desensitization in solid organ transplantation","volume":"12","author":"Schinstock","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1053\/j.akdh.2024.08.004_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjms.2021.05.011","article-title":"Non-adherence to appointments is a strong predictor of medication non-adherence and outcomes in kidney transplant recipients","volume":"362","author":"Mohamed","year":"2021","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1053\/j.akdh.2024.08.004_bib41","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2215\/CJN.11991019","article-title":"Evaluation and treatment of acute rejection in kidney allografts","volume":"15","author":"Cooper","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1053\/j.akdh.2024.08.004_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.942665","article-title":"Belatacept in kidney transplantation: what are the true benefits? A systematic review","volume":"9","author":"Lombardi","year":"2022","journal-title":"Front Med"},{"issue":"4","key":"10.1053\/j.akdh.2024.08.004_bib43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and long-term outcomes in kidney transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib44","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ajt.2023.09.011","article-title":"Belatacept with time-limited tacrolimus coimmunosuppression modifies the 3-year risk of eplet mismatch in kidney transplantation","volume":"24","author":"Johnson","year":"2024","journal-title":"Am J Transplant"},{"issue":"3","key":"10.1053\/j.akdh.2024.08.004_bib45","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1600-6143.2011.03976.x","article-title":"Summary of the US FDA approval of belatacept","volume":"12","author":"Archdeacon","year":"2012","journal-title":"Am J Transplant"},{"issue":"2","key":"10.1053\/j.akdh.2024.08.004_bib46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2215\/CJN.05840710","article-title":"Switching from calcineurin inhibitor-based regimens to a belatacept-based regimen in renal\u00a0transplant recipients: a randomized phase II study","volume":"6","author":"Rostaing","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2016.09.021","article-title":"Safety and efficacy outcomes 3 years after switching to belatacept from a calcineurin inhibitor in kidney transplant recipients: results from a phase 2 randomized trial","volume":"69","author":"Griny\u00f3","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib48","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2215\/CJN.0000000000000411","article-title":"Long-term outcomes after conversion to a belatacept-based immunosuppression in kidney transplant recipients","volume":"19","author":"Divard","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.akdh.2024.08.004_bib49","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI116440","article-title":"Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles","volume":"91","author":"Lanese","year":"1993","journal-title":"J Clin Invest"},{"author":"Randhawa","key":"10.1053\/j.akdh.2024.08.004_bib50"}],"container-title":["Advances in Kidney Disease and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924001332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949813924001332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T01:20:16Z","timestamp":1733016016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949813924001332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2949813924001332"],"URL":"https:\/\/doi.org\/10.1053\/j.akdh.2024.08.004","relation":{},"ISSN":["2949-8139"],"issn-type":[{"type":"print","value":"2949-8139"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transplant Nephrology","name":"articletitle","label":"Article Title"},{"value":"Advances in Kidney Disease and Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.akdh.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the National Kidney Foundation, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}